Alex Harocopos

1.1k total citations
32 papers, 820 citations indexed

About

Alex Harocopos is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Toxicology. According to data from OpenAlex, Alex Harocopos has authored 32 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Public Health, Environmental and Occupational Health, 22 papers in Epidemiology and 7 papers in Toxicology. Recurrent topics in Alex Harocopos's work include Opioid Use Disorder Treatment (25 papers), HIV, Drug Use, Sexual Risk (15 papers) and Substance Abuse Treatment and Outcomes (13 papers). Alex Harocopos is often cited by papers focused on Opioid Use Disorder Treatment (25 papers), HIV, Drug Use, Sexual Risk (15 papers) and Substance Abuse Treatment and Outcomes (13 papers). Alex Harocopos collaborates with scholars based in United States and Puerto Rico. Alex Harocopos's co-authors include Bennett Allen, Michelle Teti, Karol Silva, Stephen E. Lankenau, Jennifer Jackson Bloom, Michael C. Clatts, Lloyd A. Goldsamt, Denise Paone, Nisha Beharie and Adelya Urmanche and has published in prestigious journals such as American Journal of Public Health, Drug and Alcohol Dependence and JAMA Network Open.

In The Last Decade

Alex Harocopos

29 papers receiving 791 citations

Peers

Alex Harocopos
Sharon Stancliff United States
Amy Gibson Australia
Thomas Santo Australia
Darius A. Rastegar United States
Jennifer Carroll United States
Zoe Weinstein United States
Alexandria Macmadu United States
Alex S. Bennett United States
George Karandinos United States
Fernando Montero United States
Sharon Stancliff United States
Alex Harocopos
Citations per year, relative to Alex Harocopos Alex Harocopos (= 1×) peers Sharon Stancliff

Countries citing papers authored by Alex Harocopos

Since Specialization
Citations

This map shows the geographic impact of Alex Harocopos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Harocopos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Harocopos more than expected).

Fields of papers citing papers by Alex Harocopos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Harocopos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Harocopos. The network helps show where Alex Harocopos may publish in the future.

Co-authorship network of co-authors of Alex Harocopos

This figure shows the co-authorship network connecting the top 25 collaborators of Alex Harocopos. A scholar is included among the top collaborators of Alex Harocopos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex Harocopos. Alex Harocopos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jordan, Ashly E., et al.. (2025). Piloting a Point-of-Care Drug-Checking Service at Syringe Service Programs in New York City. PubMed. 47(2). 564–569.
2.
Behrends, Czarina N., Michelle L. Nolan, Ashly E. Jordan, et al.. (2025). Expanded Naloxone Distribution by Opioid Overdose Prevention Programs to High-Need Populations and Neighborhoods in New York City. Journal of Urban Health. 102(2). 459–464.
3.
Harocopos, Alex, et al.. (2025). The prevalence of fentanyl in New York City’s unregulated drug supply as measured through drug checking offered at syringe service programs. Drug and Alcohol Dependence. 268. 112578–112578. 3 indexed citations
4.
Harocopos, Alex, et al.. (2025). Community-based drug checking at syringe service programs in New York City observe an increasing prevalence of xylazine from 2021 through 2024. Harm Reduction Journal. 22(1). 99–99. 2 indexed citations
5.
Eschliman, Evan L., Yue Fei, Chris Kang, et al.. (2024). Evaluation of Two Videos that Apply Evidence-Based Strategies to Increase Self-Efficacy and Reduce Opioid-Related Stigma Among Medical Students. Academic Psychiatry. 48(2). 123–134.
6.
Harocopos, Alex, et al.. (2023). The Nation’s First Publicly Recognized Overdose Prevention Centers: Lessons Learned in New York City. Journal of Urban Health. 100(2). 245–254. 18 indexed citations
7.
Beharie, Nisha, Adelya Urmanche, & Alex Harocopos. (2023). A mixed-methods analysis of risk-reduction strategies adopted by syringe services program participants and non-syringe services program participants in New York City. Harm Reduction Journal. 20(1). 38–38. 5 indexed citations
8.
Urmanche, Adelya, Nisha Beharie, & Alex Harocopos. (2022). Fentanyl preference among people who use opioids in New York City. Drug and Alcohol Dependence. 237. 109519–109519. 12 indexed citations
9.
Jakubowski, Andrea, Alex Harocopos, Alice E. Welch, et al.. (2022). Implementation of buprenorphine services in NYC syringe services programs: a qualitative process evaluation. Harm Reduction Journal. 19(1). 75–75. 8 indexed citations
10.
Allen, Bennett, et al.. (2021). Primary Care Implementation of a Mandatory Prescription Drug Monitoring Program in New York City. The Journal of Behavioral Health Services & Research. 49(2). 122–133. 1 indexed citations
11.
Nolan, Michelle L., et al.. (2021). Racial disparities in criminal legal system involvement among New York City overdose decedents: Implications for diversion programs. Drug and Alcohol Dependence. 226. 108867–108867. 9 indexed citations
12.
Beharie, Nisha, et al.. (2021). “I didn't feel like a number”: The impact of nurse care managers on the provision of buprenorphine treatment in primary care settings. Journal of Substance Abuse Treatment. 132. 108633–108633. 14 indexed citations
13.
Nolan, Michelle L., Alex Harocopos, Bennett Allen, & Denise Paone. (2020). Reformulation of oxycodone 80 mg to prevent misuse: A cohort study assessing the impact of a supply-side intervention. International Journal of Drug Policy. 83. 102848–102848. 7 indexed citations
14.
Allen, Bennett & Alex Harocopos. (2016). Non-Prescribed Buprenorphine in New York City: Motivations for Use, Practices of Diversion, and Experiences of Stigma. Journal of Substance Abuse Treatment. 70. 81–86. 61 indexed citations
15.
Harocopos, Alex, Bennett Allen, & Denise Paone. (2015). Circumstances and contexts of heroin initiation following non-medical opioid analgesic use in New York City. International Journal of Drug Policy. 28. 106–112. 33 indexed citations
16.
Lankenau, Stephen E., et al.. (2012). Patterns of Prescription Drug Misuse among Young Injection Drug Users. Journal of Urban Health. 89(6). 1004–1016. 61 indexed citations
17.
Lankenau, Stephen E., et al.. (2011). Initiation into prescription opioid misuse amongst young injection drug users. International Journal of Drug Policy. 23(1). 37–44. 304 indexed citations
18.
Goldsamt, Lloyd A., et al.. (2010). Hepatitis C knowledge among new injection drug users. Drugs Education Prevention and Policy. 17(6). 821–834. 11 indexed citations
19.
Goldsamt, Lloyd A., et al.. (2010). Circumstances, Pedagogy and Rationales for Injection Initiation Among New Drug Injectors. Journal of Community Health. 35(3). 258–267. 55 indexed citations
20.
Harocopos, Alex, et al.. (2008). New injectors and the social context of injection initiation. International Journal of Drug Policy. 20(4). 317–323. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sharon Stancliff Breakdown of academic impact, for papers by Amy Gibson Breakdown of academic impact, for papers by Thomas Santo Breakdown of academic impact, for papers by Darius A. Rastegar Breakdown of academic impact, for papers by Jennifer Carroll Breakdown of academic impact, for papers by Zoe Weinstein Breakdown of academic impact, for papers by Alexandria Macmadu Breakdown of academic impact, for papers by Alex S. Bennett Breakdown of academic impact, for papers by George Karandinos Breakdown of academic impact, for papers by Fernando Montero
Rankless by CCL
2026